Is self-administered DMPA an answer to contraception access in the post-Roe era?

Lindsay Nakaishi; Gregory Castelli

doi:10.12788/jfp.0558

Is self-administered DMPA an answer to contraception access in the post-Roe era?

J Fam Pract. 2023 Mar;72(2):84-86. doi: 10.12788/jfp.0558.

Authors

Lindsay Nakaishi¹, Gregory Castelli¹

Affiliation

¹ UPMC St. Margaret Family Medicine Residency Program, Pittsburgh, PA.

Abstract

Compared with provider-administered depot medroxyprogesterone acetate, a prefilled formulation may offer patients improved access to effective contraception.

MeSH terms

Contraception
Contraceptive Agents, Female*
Female
Health Services Accessibility
Humans
Medroxyprogesterone Acetate* / therapeutic use

Substances

Medroxyprogesterone Acetate
Contraceptive Agents, Female